- Home
- IMMR vs OCGN Comparison
IMMR vs OCGN Comparison
Compare IMMR & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMR
- OCGN
- Stock Information
- Founded
- IMMR 1993
- OCGN 2013
- Country
- IMMR United States
- OCGN United States
- Employees
- IMMR N/A
- OCGN N/A
- Industry
- IMMR Computer peripheral equipment
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMMR Technology
- OCGN Health Care
- Exchange
- IMMR Nasdaq
- OCGN Nasdaq
- Market Cap
- IMMR 247.2M
- OCGN 278.3M
- IPO Year
- IMMR 1999
- OCGN N/A
- Fundamental
- Price
- IMMR $8.11
- OCGN $0.96
- Analyst Decision
- IMMR Strong Buy
- OCGN Strong Buy
- Analyst Count
- IMMR 2
- OCGN 3
- Target Price
- IMMR $12.25
- OCGN $6.00
- AVG Volume (30 Days)
- IMMR 492.6K
- OCGN 8.7M
- Earning Date
- IMMR 08-19-2025
- OCGN 08-07-2025
- Dividend Yield
- IMMR 2.21%
- OCGN N/A
- EPS Growth
- IMMR 57.07
- OCGN N/A
- EPS
- IMMR 2.04
- OCGN N/A
- Revenue
- IMMR $163,133,000.00
- OCGN $4,522,000.00
- Revenue This Year
- IMMR $988.71
- OCGN N/A
- Revenue Next Year
- IMMR $109.72
- OCGN N/A
- P/E Ratio
- IMMR $3.98
- OCGN N/A
- Revenue Growth
- IMMR 338.21
- OCGN N/A
- 52 Week Low
- IMMR $6.47
- OCGN $0.52
- 52 Week High
- IMMR $13.94
- OCGN $1.98
- Technical
- Relative Strength Index (RSI)
- IMMR 62.57
- OCGN 44.55
- Support Level
- IMMR $7.61
- OCGN $0.95
- Resistance Level
- IMMR $7.95
- OCGN $1.09
- Average True Range (ATR)
- IMMR 0.23
- OCGN 0.09
- MACD
- IMMR 0.02
- OCGN -0.03
- Stochastic Oscillator
- IMMR 90.00
- OCGN 6.07
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").